{"url":"https://lda.senate.gov/api/v1/filings/134d4ff9-e515-40b0-ab30-55547aa7a2be/","filing_uuid":"134d4ff9-e515-40b0-ab30-55547aa7a2be","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2019,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/134d4ff9-e515-40b0-ab30-55547aa7a2be/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Rinderman","dt_posted":"2019-07-16T14:28:00.593000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"8941 Jefferson Highway","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"Baton Rouge","registrant_state":"LA","registrant_zip":"70809","registrant":{"id":400786367,"url":"https://lda.senate.gov/api/v1/registrants/400786367/","house_registrant_id":null,"name":"TAUZIN STRATEGIC NETWORKS","description":"Strategic advice.","address_1":"19343 E. US Hwy 57","address_2":null,"address_3":null,"address_4":null,"city":"Batesville","state":"TX","state_display":"Texas","zip":"78829","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AIDAN ADAMS","contact_telephone":"+1 307-399-2226","dt_updated":"2026-07-02T12:48:16.659691-04:00"},"client":{"id":195306,"url":"https://lda.senate.gov/api/v1/clients/195306/","client_id":176,"name":"CAPTURERX","general_description":"Pharmaceutical third party administrator","client_government_entity":false,"client_self_select":null,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-01-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the 340b program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55181,"prefix":"mr","prefix_display":"MR.","first_name":"W.J.","nickname":"BILLY","middle_name":null,"last_name":"TAUZIN","suffix":null,"suffix_display":null},"covered_position":"Member of Congress (LA-3)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the 340b program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55181,"prefix":"mr","prefix_display":"MR.","first_name":"W.J.","nickname":"BILLY","middle_name":null,"last_name":"TAUZIN","suffix":null,"suffix_display":null},"covered_position":"Member of Congress (LA-3)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}